{"id":"https://openalex.org/W2000482018","doi":"https://doi.org/10.2337/diacare.19.6.642","title":"An Importance of Carbohydrate Ingestion for the Expression of the Effect of \u03b1-Glucosidase Inhibitor in NIDDM","display_name":"An Importance of Carbohydrate Ingestion for the Expression of the Effect of \u03b1-Glucosidase Inhibitor in NIDDM","publication_year":1996,"publication_date":"1996-06-01","ids":{"openalex":"https://openalex.org/W2000482018","doi":"https://doi.org/10.2337/diacare.19.6.642","mag":"2000482018","pmid":"https://pubmed.ncbi.nlm.nih.gov/8725865"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.19.6.642","doi":"https://doi.org/10.2337/diacare.19.6.642","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.19.6.642","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113465738","display_name":"Tomohiro Hara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomohiro Hara","raw_affiliation_strings":["Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106027150","display_name":"Jiro Nakamura","orcid":"https://orcid.org/0000-0003-3385-6916","observed_orcids":["https://orcid.org/0000-0003-3385-6916"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jiro Nakamura","raw_affiliation_strings":["Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111607301","display_name":"Naoki Koh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Koh","raw_affiliation_strings":["Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013770759","display_name":"Fumihiko Sakakibara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumihiko Sakakibara","raw_affiliation_strings":["Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077554213","display_name":"Naohide Takeuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naohide Takeuchi","raw_affiliation_strings":["Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110767050","display_name":"Nigishi Hotta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nigishi Hotta","raw_affiliation_strings":["Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Department of Internal Medicine, Nagoya University School of Medicine\u2008Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I60134161"],"apc_list":null,"apc_paid":null,"fwci":1.3357,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.77941176,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"19","issue":"6","first_page":"642","last_page":"647"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha-glucosidase-inhibitors","display_name":"alpha-glucosidase inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.949999988079071},{"id":"https://openalex.org/keywords/carbohydrate-intake","display_name":"carbohydrate intake","score":0.7049999833106995},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8939999938011169},{"id":"https://openalex.org/keywords/urinary-c-peptide","display_name":"urinary C-peptide","score":0.871999979019165},{"id":"https://openalex.org/keywords/sulfonylurea-therapy","display_name":"sulfonylurea therapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.8090000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8947502374649048},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7281874418258667},{"id":"https://openalex.org/C193230392","wikidata":"https://www.wikidata.org/wiki/Q1663054","display_name":"Ingestion","level":2,"score":0.6865804195404053},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6826648116111755},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6245238780975342},{"id":"https://openalex.org/C2778977261","wikidata":"https://www.wikidata.org/wiki/Q11358","display_name":"Carbohydrate","level":2,"score":0.5863449573516846},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.566521406173706},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5609623193740845},{"id":"https://openalex.org/C40438245","wikidata":"https://www.wikidata.org/wiki/Q130964","display_name":"Calorie","level":2,"score":0.5258132815361023},{"id":"https://openalex.org/C121446783","wikidata":"https://www.wikidata.org/wiki/Q208353","display_name":"Circadian rhythm","level":2,"score":0.5172589421272278},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5049691796302795},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.4762451946735382},{"id":"https://openalex.org/C2776652674","wikidata":"https://www.wikidata.org/wiki/Q273924","display_name":"Glycemic index","level":4,"score":0.425503134727478},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4120626747608185}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D002149","descriptor_name":"Energy Intake","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004040","descriptor_name":"Dietary Carbohydrates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007297","descriptor_name":"Inpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014044","descriptor_name":"Tolbutamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D065089","descriptor_name":"Glycoside Hydrolase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2337/diacare.19.6.642","doi":"https://doi.org/10.2337/diacare.19.6.642","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.19.6.642","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:8725865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8725865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2145276190","https://openalex.org/W2153448684","https://openalex.org/W2013843275","https://openalex.org/W1996784849","https://openalex.org/W2417900021","https://openalex.org/W2101774087","https://openalex.org/W1998869732","https://openalex.org/W2029630234","https://openalex.org/W1932455546","https://openalex.org/W1980062765"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"examine":[2],"the":[3,23,57,92,104,109,135,166,169,178,198,211],"usefulness":[4],"of":[5,11,17,22,25,37,94,99,200,213],"alpha-glucosidase":[6,26,54,132],"inhibitors":[7,27,55,133,187],"in":[8,20,96,121,142,152,168,177,193,202],"glycemic":[9,191],"control":[10,192],"patients":[12,39,44,194],"with":[13,41,131,195],"NIDDM.":[14],"The":[15],"involvement":[16],"carbohydrate":[18,201],"ingestion":[19],"manifestation":[21],"effects":[24],"was":[28],"also":[29],"investigated.":[30],"RESEARCH":[31],"DESIGN":[32],"AND":[33],"METHODS:":[34],"A":[35],"total":[36],"41":[38],"hospitalized":[40],"NIDDM":[42,196],"(22":[43],"receiving":[45,49],"sulfonylurea":[46],"and":[47,75,108,126,146,148,197],"19":[48],"insulin":[50],"therapy)":[51],"were":[52,64,68,84],"given":[53],"during":[56,101,134],"period":[58],"when":[59],"their":[60,214],"blood":[61,122,143],"glucose":[62,123,144],"levels":[63,145],"well":[65],"controlled.":[66],"They":[67,83],"followed":[69],"for":[70,76,190,210],"3":[71],"weeks":[72],"as":[73,81],"inpatients":[74],"an":[77,207],"additional":[78],"6":[79,163,183],"months":[80,164],"outpatients.":[82],"retrospectively":[85],"divided":[86],"into":[87],"two":[88,115],"groups":[89],"according":[90],"to":[91,158],"percentage":[93,199],"carbohydrates":[95],"all":[97,203],"sources":[98,205],"calories":[100],"outpatient":[102],"management:":[103],"<":[105,170],"50%":[106,111,171,180],"group":[107,181],">":[110,179],"group.":[112],"Between":[113],"these":[114],"groups,":[116],"we":[117],"compared":[118],"circadian":[119,140],"variation":[120,141],"levels,":[124],"HbA1c,":[125],"urine":[127,150],"C-peptide.":[128],"RESULTS:":[129],"Treatment":[130],"hospital":[136],"stay":[137],"markedly":[138],"improved":[139,176],"HbA1c":[147,156,173],"decreased":[149],"C-peptide":[151],"both":[153],"groups.":[154],"While":[155],"returned":[157],"its":[159],"pretreatment":[160],"level":[161],"at":[162,182],"after":[165],"treatment":[167],"group,":[172],"had":[174],"further":[175],"months.":[184],"CONCLUSIONS:":[185],"alpha-Glucosidase":[186],"are":[188],"useful":[189],"calorie":[204],"is":[206],"important":[208],"factor":[209],"expression":[212],"effects.":[215]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}